Latest News

Neurodegenerative disease advance: Study details how brain enzyme interacts with drug-like lead compound for Huntington's

A significant breakthrough has been made towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. Researchers have detailed how an enzyme in the brain interacts with a promising drug-like lead compound for Huntington's disease to inhibit its activity. Their findings demonstrate that it can be developed as an effective treatment for neurodegenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How the stress hormone cortisol reinforces traumatic memories

  • Documenting how dementia sufferers benefit from GPS

  • Prion trials and tribulations: Finding the right tools and experimental models

  • Puccini?s ?exotic inspiration?:Unusual source of Madam Butterfly's melodies revealed

  • Online reader comments can provide valuable feedback to news sites

  • Pinpointing mutations in a relapsed children's cancer may lead to improved treatments

  • Infection with Wolbachia bacteria curbs fighting among fruit flies

  • Rapid response to kids' stroke symptoms may speed diagnosis

  • Commonly prescribed drugs affect decisions to harm oneself and others

  • Long-term memories are maintained by prion-like proteins

  •